Jacob D. Cohen Amends MANGOCEUTICALS Stake, Joins Shareholder Group

TL;DR

**Major shareholder Jacob D. Cohen just updated his stake in MANGOCEUTICALS, INC. and is now part of a group, watch for potential activism!**

AI Summary

Jacob D. Cohen, a significant shareholder in MANGOCEUTICALS, INC., filed an amended SC 13D/A on December 28, 2023, indicating a change in his beneficial ownership. This amendment, filed on January 2, 2024, updates his previous filing and shows he is now part of a group, which can signal a more coordinated effort to influence the company. Investors should note this as it could lead to strategic shifts or increased shareholder activism, potentially impacting the stock's future direction.

Why It Matters

This filing indicates a change in a major shareholder's position and strategy, potentially signaling future corporate actions or increased influence over MANGOCEUTICALS, INC.

Risk Assessment

Risk Level: medium — Changes in significant shareholder groups can lead to unpredictable corporate actions or governance shifts, introducing moderate risk for investors.

Analyst Insight

Investors should monitor future filings and company announcements from MANGOCEUTICALS, INC. for any signs of increased shareholder activism or strategic shifts, as Jacob D. Cohen's new group affiliation could lead to significant changes.

Key Players & Entities

• Jacob D. Cohen (person) — Reporting Person and significant shareholder of MANGOCEUTICALS, INC.
• MANGOCEUTICALS, INC. (company) — The Issuer of the Common Stock
• 03 Life Sciences (company) — Organization Name associated with MANGOCEUTICALS, INC.
• December 28, 2023 (date) — Date of event requiring the filing of this statement
• January 2, 2024 (date) — Date the filing was made public

Forward-Looking Statements

• Jacob D. Cohen, as part of a group, will likely increase his influence on MANGOCEUTICALS, INC.'s strategic decisions. (Jacob D. Cohen) — medium confidence, target: Q2 2024

FAQ

Key Financial Figures

• $0.0001 — INC. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class o
• $0.32 — of common stock at an exercise price of $0.32 per share and an expiration date of Dec
• $1.10 — of common stock at an exercise price of $1.10 per share and an expiration date of Aug

Filing Documents

• formsc13da.htm (SC 13D/A) — 77KB
• 0001493152-23-046642.txt ( ) — 79KB

From the Filing

SC 13D/A 1 formsc13da.htm UNITED SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* MANGOCEUTICALS, INC. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 56270V106 (CUSIP Number) Jacob D. Cohen 15110 N. Dallas Parkway, Suite 600 Dallas, Texas 75248 (214) 242-9619 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) December 28, 2023 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Note : Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be “ filed ” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“ Act ”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 56270V106 Schedule 13D/A Amendment No. 1 Page 2 of 6 1. Name of Reporting Person Jacob D. Cohen 2. Check the Appropriate Box if a Member of a Group. (a) (b) 3. SEC Use Only 4. Source of Funds OO 5. Check if Disclosure of Legal Proceedings is Required Pursuant to Item 2(d) or 2(e) 6. Citizenship or Place of Organization United Number of Shares Beneficially Owned by Each Reporting Person With 7. Sole Voting Power 1,500,000 shares* (1) 8. Shared Voting Power 8,275,000 shares* 9. Sole Dispositive Power 1,500,000 shares* (1) 10. Shared Dispositive Power 8,275,000 shares* 11. Aggregate Amount Beneficially Owned by Each Reporting Person 9,775,000 shares* 12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares. 13. Percent of Class Represented by Amount in Row (11) 42.6%* 14. Type of Reporting Person IN * All percentages are based on 21,419,500 shares of Common Stock outstanding as of December 28, 2023, as confirmed by the Issuer’s transfer agent on such date. (1) Includes 1,250,000 shares of common stock issuable upon exercise of options to purchase shares of common stock at an exercise price of $0.32 per share and an expiration date of December 28, 2028, and 250,000 shares of common stock issuable upon exercise of options to purchase shares of common stock at an exercise price of $1.10 per share and an expiration date of August 31, 2027. CUSIP No. 56270V106 Schedule 13D/A Amendment No. 1 Page 3 of 6 1. Name of Reporting Person The Tiger Cub Trust 2. Check the Appropriate Box if a Member of a Group. (a) (b) 3. SEC Use Only 4. Source of Funds OO 5. Check if Disclosure of Legal Proceedings is Required Pursuant to Item 2(d) or 2(e). 6. Citizenship or Place of Organization Texas Number of Shares Beneficially Owned by Each Reporting Person With 7. Sole Voting Power -0- shares 8. Shared Voting Power 8,275,000 shares 9. Sole Dispositive Power -0- shares 10. Shared Dispositive Power 8,275,000 shares 11. Aggregate Amount Beneficially Owned by Each Reporting Person 8,275,000 shares 12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares. 13. Percent of Class Represented by Amount in Row (11) 38.6%* 14. Type of Reporting Person OO * All percentages are based on 21,419,500 shares of Common Stock outstanding as of December 28, 2023, as confirmed by the Issuer’s transfer agent on such date. CUSIP No. 56270V106 Schedule 13D/A Amendment No. 1 Page 4 of 6 This Amendment No. 1 (the “ Amendment ”) amends and supplements the Schedule 13D filed with the Securities and Exchange Commission (the “ Commission ”) on May 3, 2023, by Jacob D. Cohen and The Tiger Cub Trust (the Schedule 13D as amended and modified by Amendment No. 1, the “ Schedule 13D ”). Capitalized terms used but not otherwise defined in this Amendment have the meanings ascribed to such terms in the Schedule 13D. Except as expressly amended and supplemented by this Amendment, the Schedule 13D is not amended or supplemented in any respect, and the disclosures set forth in the Schedule 13D, other than as amended herein are incorporated by reference herein. Ite

View Full Filing

View this SC 13D/A filing on SEC EDGAR